When a medical device enters the market, the journey of ensuring its safety and effectiveness does not end — it enters a new phase. For companies like Mona Care, which provides a wide range of life care and rehabilitation products, clinical follow-up studies serve as a critical bridge between regulatory approval and real-world patient outcomes. But what exactly is a clinical follow-up study, and how does it apply to products such as nursing beds, lower limb rehabilitation exoskeletons, and other care devices offered by Mona Care?
A clinical follow-up study, often referred to in regulatory frameworks as Post-Market Clinical Follow-up (PMCF), is a systematic process of collecting and evaluating clinical data from a medical device after it has been authorized for sale. The goal is to confirm that the device continues to perform safely and effectively when used in everyday clinical environments, across diverse patient populations and healthcare settings.
Unlike premarket clinical investigations, which are conducted under controlled conditions with a limited number of subjects, clinical follow-up studies capture what happens in the real world. They help identify rare adverse events, confirm long-term safety, and validate that the clinical benefits seen during initial testing hold up over months and years of routine use.
Mona Care's product range spans several categories that directly impact patient health and mobility. From electric nursing beds used in both hospitals and homes, to advanced exoskeleton robots designed for gait rehabilitation, every product interacts closely with the human body. This makes post-market clinical monitoring especially important.
There are several reasons why clinical follow-up studies are essential for these types of care products:
Mona Care works in partnership with rehabilitation departments, neurology units, intensive care facilities, and home care providers to gather meaningful clinical data. The company's approach to clinical follow-up is built on several key principles:
Several product categories in the Mona Care portfolio are subject to ongoing clinical follow-up, each with distinct monitoring objectives:
Mona Care's electric nursing beds — including the Electric Multifunction Rotating Nursing Bed — are used in welfare institutions and home care settings. Clinical follow-up for these products focuses on long-term mechanical reliability, pressure sore prevention outcomes, ease of use for caregivers, and patient comfort during extended bed rest. Features such as back lifting, leg adjustment, left and right turning, and in-bed toilet functionality are monitored to ensure they continue to meet the needs of both patients and caregivers over months and years of daily use.
The lower limb rehabilitation exoskeleton lineup — including Bear Adult, Rabbit Kid, and Gait Assist — represents some of the most technologically advanced products in the Mona Care catalog. These devices, which are IEC 60601 certified for safety and reliability, are used in rehabilitation departments, neurology, and neurosurgery units. Clinical follow-up studies for exoskeletons track gait improvement metrics, patient adherence to training protocols, device durability under repetitive high-frequency use, and the consistency of torque output. For the Rabbit Kid model, which has been deployed in schools and children's hospitals in Hong Kong, follow-up data also captures outcomes specific to pediatric populations with lower limb motor function disorders.
The Hug Moving patient transfer device and the Walking Robot & Wheel Chair combination are designed to assist with safe patient mobility. Clinical follow-up for these devices centers on caregiver ergonomics, fall prevention outcomes, and the ease with which patients can be transferred between beds, chairs, and other surfaces without injury to either the patient or the caregiver.
The B-CURE Laser Pain Relief device and the automated washing robot are also included in Mona Care's clinical follow-up program. For the laser therapy device, follow-up studies monitor pain reduction outcomes, treatment consistency, and any skin-related side effects. For the washing robot, the focus is on hygiene effectiveness, patient comfort, and the device's ability to reduce caregiver workload in daily bathing routines.
The ultimate value of clinical follow-up studies lies in the tangible benefits they deliver to end users. For patients using Mona Care products, ongoing clinical monitoring means:
For caregivers — whether family members at home or professional staff in medical institutions — clinical follow-up data helps establish best practices for device usage, reduces the risk of injury during patient handling, and provides evidence-based guidance on integrating assistive devices into daily care routines.
Mona Care's clinical follow-up activities are guided by internationally recognized standards. The company's walking robots, for instance, have received IEC 60601 certification, which addresses the safety and essential performance of medical electrical equipment. This certification is not a one-time achievement — it requires ongoing evidence that the device continues to meet safety benchmarks throughout its commercial life, and clinical follow-up data is a key component of maintaining that evidence.
Additionally, guidance from the International Medical Device Regulators Forum (IMDRF) outlines the circumstances under which post-market clinical follow-up studies should be conducted, the elements that a well-designed study should include, and how the resulting information should be used to update risk management files and clinical evaluation reports.
A clinical follow-up study is far more than a regulatory checkbox — it is a commitment to patient safety and product excellence that extends across the entire lifecycle of a medical device. For Mona Care, this commitment is woven into every product category, from nursing beds to lower limb rehabilitation exoskeletons. By continuously gathering, analyzing, and acting on real-world clinical data, Mona Care ensures that its products not only meet regulatory requirements but also genuinely improve the quality of life for patients and caregivers around the world.